Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FRQ41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,147
Award facts
- Contract value 100% obligated
- $17,147.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Ondansetron ODT 4 MG tablets (30-count supply) with a ceiling value of $17,147.07. This is a firm fixed-price delivery order executed without a set-aside designation, indicating competitive award through open competition. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery fulfills pharmaceutical supply requirements for federal military and healthcare operations.
This delivery order leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally. AmerisourceBergen is a major pharmaceutical distributor serving critical federal medical procurement needs, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established track record in delivering diverse pharmaceutical commodities—including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains—positions it as a primary supplier within the DLA's pharmaceutical supply chain supporting military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FRQ41?
SPE2DB25FRQ41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FRQ41 worth?
The government has obligated $17,147 on SPE2DB25FRQ41.
Is contract SPE2DB25FRQ41 an order under another contract?
Yes. SPE2DB25FRQ41 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRQ41 competed?
The extent of competition for SPE2DB25FRQ41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award